Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 5, 2025Science AdvancesOpen Access

Tumor microenvironment–targeted PROTAC nanoparticle self-assembly broadly predicted by structural descriptors

View Full Paper
Ask AI
Bookmark
Share

Authors

MPMagdalini PanagiotakopoulouXHXiaoping HuSRStephen Ruiz

Discussion

Loading...

Member takes

Overview

Findings reveal nanoparticle PROTACs improve drug uptake in tumors while enhancing pharmacologic properties and therapeutic index.

Key Points

  • Nanoparticle PROTACs reportedly enhance tumor drug uptake significantly, improving overall survival in solid tumors.
  • With 96% sensitivity and 100% specificity, spatial autocorrelation molecular descriptors predict nanoPROTAC formation.
  • This innovative approaches emphasizes the development of self-assembling nanoparticles for targeted therapy in tumors.
  • The strategy aims to improve therapeutic indices of proteolysis-targeting chimeras and similar therapeutics.

Cite This Study

Panagiotakopoulou et al. (2025) studied this question.

synapsesocial.com/papers/6940225c2d562116f28fc5fdhttps://doi.org/10.1126/sciadv.adu2292
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Nano-Proteolysis Targeting Chimeras (Nano-PROTACs) in Cancer Therapy2024 · 43 citations
  2. 2Recent Advances in Nanomedicine: Cutting-Edge Research on Nano-PROTAC Delivery Systems for Cancer Therapy2025 · 33 citations
  3. 3Self-Assembling Amphiphilic PROTACs: A Chemical Strategy for Improved EGFR-Targeted Protein Degradation2026 · 1 citations
  4. 4Anticancer Therapy with Proteolysis-targeting Chimeras [PROTACs] Targeting Towards the Tumor-microenvironment: Development, Current State and Prospects2024 · 1 citations
  5. 5Pretargeted PROTAC Strategy Enables Precise Tumor Target Degradation <i>via</i> Self-Assembling Peptides2026